<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812454269</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812454269</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Response to “Compliance and Efficacy of Titratable Thermoplastic versus Custom Mandibular Advancement Devices” from Friedman M et al</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vanderveken</surname><given-names>Olivier M.</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Van de Heyning</surname><given-names>Paul H.</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Braem</surname><given-names>Marc J.</given-names></name>
<degrees>DDS, PhD</degrees>
<aff id="aff1-0194599812454269">Department of Special Care Dentistry Antwerp University Hospital, Edegem, Antwerp, Belgium Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0194599812454269">Department of Otorhinolaryngology, Head and Neck Surgery Antwerp University Hospital, Edegem, Antwerp, Belgium Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium Email: <email>olivier.vanderveken@uza.be</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>3</issue>
<fpage>599</fpage>
<lpage>600</lpage>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>We read with great interest the recent article by Friedman et al titled “Compliance and Efficacy of Titratable Thermoplastic versus Custom Mandibular Advancement Devices.”<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup></p>
<p>Currently, mandibular advancement device (MAD) treatment is the primary alternative to continuous positive airway pressure (CPAP) therapy for patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). Potential disadvantages of custom MADs are the cost and time required to construct the device.<sup><xref ref-type="bibr" rid="bibr2-0194599812454269">2</xref></sup> As a result, thermoplastic MADs that allow for direct intraoral fitting have been evaluated.<sup><xref ref-type="bibr" rid="bibr3-0194599812454269">3</xref>,<xref ref-type="bibr" rid="bibr4-0194599812454269">4</xref></sup> It has been hypothesized that thermoplastic MADs might be used as an alternative to custom devices, saving time and cost. Thermoplastic MAD use has also been suggested as a temporary screening option to determine if success can be expected with a custom MAD. In a randomized, controlled, double-crossover trial comparing a nontitratable thermoplastic with a nontitratable custom MAD, we could demonstrate that the custom MAD was more effective than the thermoplastic MAD.<sup><xref ref-type="bibr" rid="bibr2-0194599812454269">2</xref></sup> In addition, one-third of the patients demonstrated compliance failure with the thermoplastic MAD mainly because of insufficient overnight retention.<sup><xref ref-type="bibr" rid="bibr2-0194599812454269">2</xref></sup> It seems that the side effects of thermoplastic MADs differ from those of custom MADs, with difficulty in optimal fit, leading to discomfort, and insufficient overnight retention considered the main reasons for subsequent discontinuation of thermoplastic MADs.<sup><xref ref-type="bibr" rid="bibr2-0194599812454269">2</xref>,<xref ref-type="bibr" rid="bibr5-0194599812454269">5</xref></sup></p>
<p>The article by Friedman et al<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup> is the first to compare the efficacy of a titratable thermoplastic MAD with a titratable custom MAD for the treatment of OSAHS. First, the results indicate that the overall treatment success with the custom MAD was twice as high as with the thermoplastic MAD (89.5% vs 44.7%).<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup> Second, the 6-month adherence rate for the thermoplastic MAD was only 32.5% versus 50.9% for the custom MAD.<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup> Third, in this study, the reasons for nonadherence in the custom group were again clearly different from the reasons described for nonadherence in the thermoplastic group. Discomfort (n = 10) and insufficient overnight retention (n = 5) were the most common reasons for discontinuation of the thermoplastic MAD, whereas ongoing symptoms (n = 4) was the main reason for the custom MAD.<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup></p>
<p>Friedman and colleagues<sup><xref ref-type="bibr" rid="bibr1-0194599812454269">1</xref></sup> conclude that titratable thermoplastic MADs might be a potentially useful, temporary treatment option. In our opinion, however, one should be careful about recommending MADs that show low efficacy and adherence to patients with OSAHS seeking non-CPAP treatment since a negative experience or a poor result can lead to unjustified negative generalizations concerning the effect that can be expected later with a custom MAD.</p>
<sec id="section1-0194599812454269">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812454269">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>M</given-names></name>
<name><surname>Hamilton</surname><given-names>C</given-names></name>
<name><surname>Samuelson</surname><given-names>CG</given-names></name>
<etal/></person-group>. <article-title>Compliance and efficacy of titratable thermoplastic versus custom mandibular advancement devices</article-title> [<comment>published online March 7, 2012</comment>]. <source>Otolaryngol Head Neck Surg</source>. doi:10.1177/0194599812439683<pub-id pub-id-type="doi">10.1177/0194599812439683</pub-id></citation>
</ref>
<ref id="bibr2-0194599812454269">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vanderveken</surname><given-names>OM</given-names></name>
<name><surname>Devolder</surname><given-names>A</given-names></name>
<name><surname>Marklund</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2008</year>;<volume>178</volume>:<fpage>197</fpage>-<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812454269">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vanderveken</surname><given-names>OM</given-names></name>
<name><surname>Boudewyns</surname><given-names>AN</given-names></name>
<name><surname>Braem</surname><given-names>MJ</given-names></name>
<etal/></person-group>. <article-title>Pilot study of a novel mandibular advancement device for the control of snoring</article-title>. <source>Acta Otolaryngol</source>. <year>2004</year>;<volume>124</volume>:<fpage>628</fpage>-<lpage>633</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812454269">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>M</given-names></name>
<name><surname>Pulver</surname><given-names>T</given-names></name>
<name><surname>Wilson</surname><given-names>MN</given-names></name>
<etal/></person-group>. <article-title>Otolaryngology office-based treatment of obstructive sleep apnea-hypopnea syndrome with titratable and nontitratable thermoplastic mandibular advancement devices</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2010</year>;<volume>143</volume>:<fpage>78</fpage>-<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812454269">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsuda</surname><given-names>H</given-names></name>
<name><surname>Almeida</surname><given-names>FR</given-names></name>
<name><surname>Masumi</surname><given-names>S</given-names></name>
<name><surname>Lowe</surname><given-names>AA.</given-names></name>
</person-group> <article-title>Side effects of boil and bite type oral appliance therapy in sleep apnea patients</article-title>. <source>Sleep Breath</source>. <year>2010</year>;<volume>14</volume>:<fpage>227</fpage>-<lpage>232</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>